13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis
暂无分享,去创建一个
Wolfgang Wiechert | Katharina Nöh | Sebastian Niedenführ | Jane L. Ward | Michael H. Beale | Johnjoe McFadden | W. Wiechert | J. McFadden | Nathaniel D Hawkins | D. Beste | S. Niedenführ | J. Ward | K. Nöh | M. H. Beale | T. Mendum | Dany J.V. Beste | Tom A. Mendum | Nathaniel D. Hawkins
[1] G. Bancroft,et al. Characterization of Auxotrophic Mutants ofMycobacterium tuberculosis and Their Potential as Vaccine Candidates , 2001, Infection and Immunity.
[2] Christopher M. Sassetti,et al. Mycobacterial persistence requires the utilization of host cholesterol , 2008, Proceedings of the National Academy of Sciences.
[3] A. Mohan,et al. Multidrug-resistant tuberculosis. , 2004, The Indian journal of medical research.
[4] Sabine Ehrt,et al. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection , 2010, Proceedings of the National Academy of Sciences.
[5] Parissa Farnia,et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. , 2009, Chest.
[6] Sabine Ehrt,et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. , 2010, Chemistry & biology.
[7] K. Kuhen,et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy , 2010, Nature Communications.
[8] Carolyn R Bertozzi,et al. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. , 2012, Chemistry & biology.
[9] Alladi Mohan,et al. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. , 2006, Chest.
[10] V. Subbulakshmi,et al. Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. , 2009, Microbiology.
[11] E. Muñoz-Elías,et al. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence , 2005, Nature Medicine.
[12] T. Weisbrod,et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis , 1995, Infection and immunity.
[13] S. Klamt,et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism , 2007, Genome Biology.
[14] P. Verma,et al. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. , 2012, Cell host & microbe.
[15] W. Jacobs,et al. Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis , 2000, Infection and Immunity.
[16] B. Robertson,et al. Mycobacterial Mutants with Defective Control of Phagosomal Acidification , 2005, PLoS pathogens.
[17] W. Eisenreich,et al. Isotopologue Profiling of Legionella pneumophila , 2010, The Journal of Biological Chemistry.
[18] H. Kornfeld,et al. THP-1 Cell Apoptosis in Response to Mycobacterial Infection , 2003, Infection and Immunity.
[19] David G. Russell,et al. Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress* , 2013, The Journal of Biological Chemistry.
[20] Bernd Freisleben,et al. Cloud MapReduce for Monte Carlo bootstrap applied to Metabolic Flux Analysis , 2013, Future Gener. Comput. Syst..
[21] W. Eisenreich,et al. Carbon Metabolism of Enterobacterial Human Pathogens Growing in Epithelial Colorectal Adenocarcinoma (Caco-2) Cells , 2010, PloS one.
[22] Harold J. Morowitz,et al. Ancient Genes in Contemporary Persistent Microbial Pathogens , 2006, The Biological Bulletin.
[23] I. Smith,et al. Global Transcriptional Profile of Mycobacterium tuberculosis during THP-1 Human Macrophage Infection , 2007, Infection and Immunity.
[24] R. Brosch,et al. Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death , 2012, PLoS pathogens.
[25] D. Schnappinger,et al. Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. , 2011, Cell host & microbe.
[26] M. Horwitz,et al. Glutamine Synthetase GlnA1 Is Essential for Growth of Mycobacterium tuberculosis in Human THP-1 Macrophages and Guinea Pigs , 2003, Infection and Immunity.
[27] W. Jacobs,et al. Protection Elicited by Two Glutamine Auxotrophs of Mycobacterium tuberculosis and In Vivo Growth Phenotypes of the Four Unique Glutamine Synthetase Mutants in a Murine Model , 2006, Infection and Immunity.
[28] W Wiechert,et al. A universal framework for 13C metabolic flux analysis. , 2001, Metabolic engineering.
[29] Sarman Singh,et al. Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis , 2010, Cell.
[30] Digby F. Warner,et al. Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids , 2008, Journal of bacteriology.
[31] Alberto Mantovani,et al. Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.
[32] S. Noack,et al. 13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation , 2011, PLoS pathogens.
[33] T. Dandekar,et al. 13C isotopologue perturbation studies of Listeria monocytogenes carbon metabolism and its modulation by the virulence regulator PrfA , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] Wolfgang Wiechert,et al. 13CFLUX2—high-performance software suite for 13C-metabolic flux analysis , 2012, Bioinform..
[35] Amit Singhal,et al. Modulation of Gamma Interferon Receptor 1 by Mycobacterium tuberculosis: a Potential Immune Response Evasive Mechanism , 2007, Infection and Immunity.
[36] Uwe Sauer,et al. Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis , 2011, PLoS pathogens.